Home
Our Members
- Member Portal Login
Portfolio
Entrepreneurs
- FAQ
- Entrepreneur Resources
Become a Member
News
Job Opportunities
Contact

Home
Our Members
- Member Portal Login
Portfolio
Entrepreneurs
- FAQ
- Entrepreneur Resources
Become a Member
News
Job Opportunities
Contact

Home
Our Members
- Member Portal Login
Portfolio
Entrepreneurs
- FAQ
- Entrepreneur Resources
Become a Member
News
Job Opportunities
Contact

Portfolio

Our portfolio of companies at Robin Hood Ventures.

EXITED COMPANIES

admittedly

AgileSwitch

Aprea Therapeutics

Beckon

BioConnect Systems

cloudmine

Compoze Software

Detect-Ready Molecular Detection Inc.

E-Tech Solutions

ExpressCells

Genpro

Immunome

LiveLOOK

LoanLogics

Locus Energy

Miria Systems

Monetate

myServiceForce

Novira Therapeutics, Inc.

OcuTerra

Paradigm Spine, LLC.

Power Medical Interventions

Protez Pharmaceuticals

Synova Healthcare

Thermalin

TicketLeap

Unique Solutions Design

UTU

Robin Hood Ventures

Robin Hood Ventures is a group of experienced entrepreneurs and accredited investors looking for high-growth startups, en route to building great companies. Investments generally range from $250,000 to $1 million, and we syndicate with venture capitalists, institutions, and other angels in our network.

FUELING MID-ATLANTIC STARTUPS

View Portfolio Company Jobs

Don’t forget that we have office hours every Thu

Don’t forget that we have office hours every Thursday from 12pm-2pm!

Looking for a job? Go to http://jobs.robinhoodvent

Looking for a job? Go to http://jobs.robinhoodventures.com/jobs !

Congratulations to Virion! https://www.prnewswire

Congratulations to Virion!

https://www.prnewswire.com/news-releases/virion-therapeutics-presents-promising-preclinical-cancer-data-when-using-a-novel-genetically-encoded-checkpoint-modifier-based-immunotherapy-301762092.html

Congratulations Proscia! @PathGroupLabs has sele

Congratulations Proscia!

@PathGroupLabs
has selected Concentriq Dx!

"With Proscia’s nimbleness & speed to innovation, we will leverage the latest technology to provide the next generation of diagnosis for millions of patients.” - PathGroup CEO Ben W. Davis, MD.

https://proscia.com/press-releases/pathgroup-chooses-proscia-to-deliver-next-generation-of-cancer-diagnosis-for-millions-of-patients/?utm_source=Social&utm_medium=LinkedIn&utm_campaign=PathGroup

Follow on Instagram

Mailing Address

2526 Naudain Street
Philadelphia, PA 19146
Phone: (215) 839-6256
Fax: (484) 214-0114
Email: info@robinhoodventures.com

© Robin Hood Ventures. All Rights Reserved.

Creative: Contact Designers.